Artelo Biosciences, Inc. (ARTL)

2.68 -0.10 (-3.60%) USD  |  NASDAQ  |  May 07, 09:55
More

Artelo Biosciences Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ARTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
GlucoTrack, Inc. --
Ovid Therapeutics, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
Gossamer Bio, Inc. Upgrade